PEStore

Venture Capital

Emles Venture Partners

Emles Venture Partners backs early-stage and high-growth companies, typically pre-profit, from New York, United States. It states a focus on healthcare & life sciences, software & internet, food & beverage and financial services.

Disclosed holdings65
Earliest stated investment
HeadquartersNew York, United States
Stated fund size$25MM personal capital invested

Stated investment criteria

What Emles Venture Partners says it buys

Read from Emles Venture Partners’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

People listed on its team page31

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Emles Venture Partners to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies Emles Venture Partners lists on its own website. No investment years are published. 1 has a recorded transaction against it in the deal archive.

CompanyInvestedYears heldRecorded transaction
1910 Genetics
Alba Orbital
Arist
Asher
Austin Software
Beek Technologies
Betterhalf
Buypower
Canix
Canvas
CapWay
Commons
Delee Corp.
DirectShifts
Dribbble
EduRev
Elevat
Emi Labs
Emporus
Epic Aerospace
EquBot
Flat
Fuzionaire
Garden Society
Gridless Power
Haven Servicing
HelpNow
Henry
Homebase$523m 2016
Houm
InBalance
Jiga
Juicy Marbles
Karbon
Kredi
Lastbit
Mendel
Meru
Mesh
Meta
Mitos
Nabis
Odeko
Paradigm
Parrot
Perch
Pillar
Prometheus Fuels
R2 Capital
Radiant
Riogrande
Sable
Sequin
Shiru
Sivo
Sorting Robotics
Statiq
StayQrious
Tajir
Tizeti
TrebleAl
WareIQ
Zaraz
Zeta Surgical
inFeedo

Compiled from Emles Venture Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Emles Venture Partners?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.